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A B S T R A C T
Object: Navigated transcranial magnetic stimulation (nTMS) combined with diﬀusion tensor imaging (DTI) is
used preoperatively in patients with eloquent-located brain lesions and allows analyzing non-invasively the
spatial relationship between the tumor and functional areas (e.g. the motor cortex and the corticospinal tract
[CST]). In this study, we examined the diﬀusion parameters FA (fractional anisotropy) and ADC (apparent
diﬀusion coeﬃcient) within the CST in diﬀerent locations and analyzed their interrater reliability and usefulness
for predicting the patients' motor outcome with a precise approach of speciﬁc region of interest (ROI) seeding
based on the color-coded FA-map.
Methods: Prospectively collected data of 30 patients undergoing bihemispheric nTMS mapping followed by
nTMS-based DTI ﬁber tracking prior to surgery of motor eloquent high-grade gliomas were analyzed by 2 ex-
perienced and 1 unexperienced examiner. The following data were scrutinized for both hemispheres after
tractography based on nTMS-motor positive cortical seeds and a 2nd region of interest in one layer of the caudal
pons deﬁned by the color-coded FA-map: the pre- and postoperative motor status (day of discharge und
3 months), the closest distance between the tracts and the tumor (TTD), the fractional anisotropy (FA) and the
apparent diﬀusion coeﬃcient (ADC). The latter as an average within the CST as well as speciﬁc values in dif-
ferent locations (peritumoral, mesencephal, pontine).
Results: Lower average FA-values within the aﬀected CST as well as higher average ADC-values are signiﬁcantly
associated with deteriorated postoperative motor function (p = 0.006 and p = 0.026 respectively). Segmental
analysis within the CST revealed that the diﬀusion parameters are especially disturbed on a peritumoral level
and that the degree of their impairment correlates with motor deﬁcits (FA p = 0.065, ADC p = 0.007). No
signiﬁcant segmental variation was seen in the healthy hemisphere. The interrater reliability showed perfect
agreement for almost all analyzed parameters.
Conclusions: Adding diﬀusion weighted imaging derived information on the structural integrity of the nTMS-
based tractography results improves the predictive power for postoperative motor outcome. Utilizing a second
subcortical ROI which is speciﬁcally seeded based on the color-coded FA map increases the tracking quality of
the CST independently of the examiner's experience. Further prospective studies are needed to validate the
nTMS-based prediction of the patient's outcome.
1. Introduction
Navigated transcranial magnetic stimulation (nTMS) has been es-
tablished as a reliable, non-invasive and safe tool for analyzing cortical
motor representation and motor functionality within the scope of pre-
operative surgical planning for patients with motor eloquent brain le-
sions in a superior manner compared to fMRI (Forster et al., 2011;
Forster et al., 2014; Krieg et al., 2012b; Picht et al., 2009; Tarapore
et al., 2016; Zdunczyk et al., 2013). In these patients an extensive re-
section can lead to an increased survival and quality of life (Almenawer
et al., 2015; Hervey-Jumper and Berger, 2016; Sanai and Berger, 2008)
while inducing a new surgery-related functional deﬁcit – like a paresis –
needs to be avoided. Not only that a new deﬁcit negatively aﬀects the
patient's quality of life but it also decreases the survival (McGirt et al.,
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The accuracy of nTMS compared with the data acquired from in-
traoperative neurophysiological mapping (IOM) as the gold standard
for resection of rolandic brain tumors (Duﬀau et al., 2005; Kombos
et al., 2009a) - has been recently shown (Forster et al., 2015; Picht
et al., 2011; Tarapore et al., 2012). In addition, it is suggested that
applying preoperative nTMS mapping leads to more extensive resec-
tions and a decreased rate of postoperative motor deﬁcits (Frey et al.,
2014; Krieg et al., 2014; Picht et al., 2016).
In case of brain tumors aﬀecting the corticospinal tract (CST) nTMS-
based ﬁber tracking (FT) can be used to analyze the spatial relationship
between CST and presumed tumorous tissue (Frey et al., 2012; Krieg
et al., 2012a; Rosenstock et al., 2016; Weiss et al., 2015). Several stu-
dies have shown that a second region of interest (ROI) increases the
quality of tractography. Diﬀerent procedures for placing this second
ROI have been published (Conti et al., 2014; Frey et al., 2012; Krieg
et al., 2012a; Weiss et al., 2015).
The aim of this study was to analyze in how far the quality of nTMS-
based FT can be optimized in a user-independent and standardized
manner by seeding a 2nd ROI in one layer of the caudal pons based on
the color-coded fractional-anisotropy (FA) map (Mori and van Zijl,
2002) additionally to the cortical nTMS-based ROI. Furthermore, we
wanted to ﬁnd out to what extent the data provided by the nTMS-based
FT have prognostic value in terms of postoperative motor function.
2. Methods
2.1. Ethical standard
The study proposal is in accordance with ethical standards of the
Declaration of Helsinki and was approved by the Ethics Commission of
the Charité University Hospital (#EA4/007/06 and #EA1/037/16). All
patients provided written informed consent for medical evaluations and
treatments within the scope of the study.
2.2. Patients
Patients (n = 30) presenting with high grade glioma (according to
the WHO classiﬁcation) (Louis et al., 2007) closely located to the motor
cortex and/or the corticospinal tract (CST) between August 2011 and
March 2016 were prospectively included in this study. All of them were
operated after noninvasive functional motor mapping by nTMS for
evaluating the possibility of safe tumor resection. Study exclusion cri-
teria matched with the contraindications of TMS (> 1 generalized
seizure or cranial implants). The patients were examined neurologically
preoperatively, at the day of discharge and after 3 months by an ex-
perienced neurosurgeon. The following data were documented in a
custom-made database: age, sex, antiepileptic or antiedematous medi-
cation, Karnofsky Performance Scale (KP) (Schag et al., 1984), motor
status (according to the British Medical Research Council (MRC) grade
where 0 means no muscle activation and 5 means full muscle strength).
2.3. MRI data
A 1.5 or 3-T MR imaging unit (GE Healthcare, Milwaukee, Wis) with
an 8-channel head coil was used to perform at least a T1-weighted
contrast-enhanced 3D gradient echo sequence, T2-weighted fast spin-
echo sequence ﬂuid-attenuated inversion recovery (FLAIR) sequence
and diﬀusion tensor imaging (single-shot echo-planar sequence along
23 diﬀerent geometric directions at a b-value of 1000 s/mm2), as pre-
viously described in detail (Frey et al., 2012). All MR scans were ana-
lyzed and interpreted by an interdisciplinary board of neurosurgeons
and neuroradiologists. The T1-weighted contrast-enhanced 3D gradient
echo sequence was used to generate a 3D reconstruction with our nTMS
system (eXimia, Nexstim Oy) for navigating the stimulation location
over the cortex.
2.4. Navigated TMS mapping
Noninvasive functional motor mapping of the aﬀected and healthy
hemisphere was performed in each patient using nTMS, as speciﬁed
previously (Picht et al., 2011). Brieﬂy, the principle of electromagnetic
induction is used to produce a brief, cone-shaped magnetic ﬁeld by a
prompt discharge of a ﬁgure-of-eight stimulation coil, which then in-
duces an electric ﬁeld in the underlying brain. Depending on the sti-
mulation location and intensity, compound muscle action potentials
will be recorded by the system's integrated electromyography (EMG)
unit (sampling rate 3 kHz, resolution 0.3 mV; Neuroline 720, Ambu).
Muscle activity (MEP amplitude≥ 50 μV) is detected by surface elec-
trodes attached to the abductor pollicis brevis and ﬁrst digital inter-
osseus (FDI) of the upper extremity in each patient and – depending on
the individual tumor location – for the lower extremity to the tibialis
anterior and abductor halluces brevis muscle. The mapping is per-
formed utilizing neuronavigation where the position of the head and
the coil is tracked by an infrared tracking camera (Polaris Vicra) which
allows to control the stimulation location over the cortex with a navi-
gation accuracy of lower than or equal to 2 mm.
Prospective data collection followed a highly standardized mapping
protocol and following integration of nTMS-data into our surgical
planning software (iPlan 3.0, BrainLab) is visualized in Fig. 1.
2.5. Fiber tracking – ROI seeding
The nTMS stimuli locations along the precentral gyrus were used as
region of interest (ROI) (Fig. 1) for bihemispheric tracking of the CST
based on DTI (Rosenstock et al., 2016).
In this study, all trackings were performed with a vector step length
of 1.6 mm, an angular threshold of 30°, a minimum ﬁber length of
110 mm and 75% of the fractional anisotropy threshold (FAT) where
the FAT is the highest adjusted FA value with which a ﬁber tracking
could be performed as described previously in detail (Frey et al., 2012).
The following tractography parameters were registered: number of ﬁ-
bers belonging to the CST, number of ﬁbers not belonging to the CST
(aberrant ﬁbers, Fig. 2), the closest distance between tumor and CST,
the occurrence of edema within the CST, the volume of the tracts as
well as the fractional anisotropy (FA, measure of the directiveness of
water diﬀusion within a voxel) and the apparent diﬀusion coeﬃcient
(ADC, measure of the diﬀusivity of water within a voxel in mm2/s)
(Basser et al., 1994) measured within the CST where both values were
noted as A) average values and B) local values in diﬀerent locations
(“cortical”=most cranial part of the CST, peritumoral, mesencephal,
pontine).
We compared the tracking results following 2 diﬀerent approaches
of subcortical ROI seeding: A) conventional cubic ROI in the anterior
inferior pons – seeded by anatomical landmarks/knowledge (Weiss
et al., 2015) and B) speciﬁc plane ROI in one layer of the caudal pons
deﬁned by the color-coded FA-map (Fig. 1).
2.6. Fiber tracking with speciﬁc (color-coded, 2-dimensional) ROI
Varying values of adjusted FA values can lead to varying tracking
results where the ROIs' location highly inﬂuences them, reﬂecting dif-
ferences in local FA values (Frey et al., 2012; Negwer et al., 2016;
Negwer et al., 2017; Weiss et al., 2015). Therefore we analyzed trac-
tography results performed with the speciﬁc plane ROI and diﬀerent FA
values (0.01, 0.05, 0.1, 25% of FAT, 50% of FAT and 75% of FAT) in
terms of plausibility and tractography parameters described above to
identify the optimal tracking algorithm for the preoperative evaluation.
Moreover, the FTs of the CST based on the speciﬁc plane ROI were
reproduced for interrater reliability analysis using the 75% of FAT
protocol (Fig. 1) by one experienced examiner (> 50 ﬁber trackings
performed before) and one totally unexperienced examiner (no contact
to preoperative planning procedure before).
T. Rosenstock et al. NeuroImage: Clinical 16 (2017) 276–285
277
2.7. Preoperative evaluation and surgical procedure
The surgical planning and the implementation of nTMS-data into
the presurgical workﬂow have been outlined in detail elsewhere
(Rosenstock et al., 2016). In short, the visualization of the motor cortex
deﬁned by nTMS positive spots and the tracked CST was made available
as 3D reconstruction via the hospital's intranet for preoperative plan-
ning and for intraoperative control either on the navigational screen or
by projection into the microscope view. A detailed analysis of the
spatial relationship between tumor-suspected tissue and eloquent brain
region had been performed following a recently published risk strati-
ﬁcation model where a critical tumor location is deﬁned by inﬁltration
of the motor cortex or/and subcortical approximation to the CST equal
or< 8 mm, respectively (Rosenstock et al., 2016). The surgical strategy
was tailored to the individual case – speciﬁcally the spatial relation
between the tumor and eloquent areas. Intraoperative neurophysiolo-
gical mapping and monitoring (IOM) was performed as previously de-
scribed (Frey et al., 2014; Kombos et al., 2009a; Kombos et al., 2009b)
where the following IOM phenomena were assessed as warning criteria:
persistent MEP amplitude reduction over 50% and reproducible MEPs
with subcortical stimulation intensity of 5 mA (Rosenstock et al., 2016).
Termination of surgery was at the discretion of the individual surgeon
and based on preoperative patient consent, preoperative functional
diagnostics, IOM phenomena and general surgical circumstances like
blood loss, anesthesiological status etc.
2.8. Statistical analysis
We used descriptive statistics to analyze the patients' characteristics.
Data are presented as mean ± standard deviation (SD) in case of
Fig. 1. Illustration of our highly standardized protocol. A
patient with a (post)central glioma (WHO IV°) is presented
(A, B). Navigated TMS stimuli locations along the pre-
central gyrus were elicited with 105% RMT for the upper
and with 130%–150% RMT for the lower extremity (C) and
then exported into our ﬁber tracking software iPlan 3.0 as
region of interests with a radius of 3 mm (visualized as
yellow balls in H and I). The second ROI was seeded in one
layer of the caudal pons (E) where the blue color in the
color-coded FA-map represents the anterior-posterior pon-
tine course of the pyramidal tract (D and F). Finally, FT was
performed with 75% FAT where the tumor is colored in red,
the CST of the upper extremity in blue and the CST of the
lower extremity in green (G, H, I). In this case, we would
recommend the use of IOM – especially during the ventral
tumor debulking because the tumor seems to begin in-
ﬁltrating the CST (G).
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normal distribution or otherwise as median ± interquartile range
(IQR), respectively. The unit of the ADC is 10−4 mm2/s and is faded out
in the text for reasons of clarity. For testing the relationship between
dependent samples, we used the paired t-test for normally distributed
variables and the Wilcoxon signed-rank test otherwise or the
McNemar's test for paired nominal data, respectively. In case of in-
dependent samples, testing was performed with the student's t-test or
the Wilcoxon-Mann-Whitney test, respectively. Correlation testing was
performed by using Pearson's correlation coeﬃcient r. To detect sig-
niﬁcant association between nominal data, we used Fisher's exact test.
The interrater reliability analysis was calculated with a two-way
random single measure with absolute agreement and presented as
mean ± SD or median ± IQR, respectively, for each examiner and
intraclass correlation coeﬃcient with 95% conﬁdence intervals.
Analysis of the patients' outcome depending on the diﬀusion para-
meters has been performed in two ways: A) motor outcome (deterio-
rated vs. non-deteriorated motor status) and B) postoperative motor
status (existence of a postoperative paresis vs. no postoperative par-
esis). Additionally, the usefulness of diﬀusivity parameters for highly
signiﬁcant relations (p < 0.01) is demonstrated with ROC analysis
(receiver operating characteristics) as area under the curve (AUC) with
95% conﬁdence intervals.
The level of signiﬁcance was 0.05 (2 sided). Data analysis was
performed using SPSS (IBM SPSS Statistics version 22, IBM Corp.).
3. Results
3.1. Patients sample
Thirty patients with high grade glioma in or associated to motor
eloquent areas were prospectively enrolled for preoperative motor
mapping followed by nTMS-based DTI FT of the CST for both hemi-
spheres. The patients' characteristics are given in Table 1. Two of three
patients were under antiepileptic medication and 12 patients (40%)
received dexamethasone against edema.
3.2. Navigated TMS mapping
No seizures or persistent side eﬀects were observed during the brain
mapping. One patient (3%) complained about headache after the
mapping which disappeared within 1 h. The primary motor cortex
could be identiﬁed in all cases. The mean resting motor threshold
(RMT) for the aﬀected hemisphere was 59.3 V/m ± 15.4 and for the
healthy hemisphere was 63.1 V/m ± 13.4. The median amplitude of
the MEPs (elicited with a stimulation intensity equivalent to the RMT)
was 173 μV ± 253 for the aﬀected hemisphere and 222 μV ± 576 for
the healthy hemisphere. The mean latency of the MEPs was
23.9 ms ± 1.8 for the tumorous hemisphere and 24.2 ms ± 1.6 for
the other hemisphere.
Presence of edema within the CST decreases the mean RMT on the
aﬀected hemisphere (51 V/m ± 11.1 vs. 64 V/m ± 15.8, p = 0.024)
and decreases the median amplitude of the MEP on the healthy hemi-
sphere (120.4 μV ± 124.9 vs. 342.8 μV ± 588.2, p = 0.006) whereas
Fig. 2. Illustration of a ﬁber tracking result using an ana-
tomical-seeded cubic ROI. The same protocol like described
in Fig. 1 is used except the second ROI which is placed as
orange cubic box in the anterior inferior pons (A). Aberrant
ﬁbers, clearly not belonging to the CST, are also visualized.
Using this results for planning the surgical resection
strategy could lead to an unnecessary restricted resection
because aberrant ﬁbers running through the tumor might
be preserved by the surgeon (B).
Table 1
Demographic and clinical characteristics of the patients.
Patients





















WHO III 4 (13%)
WHO III (rec.) 1 (3%)
WHO IV 23 (77%)
WHO IV (rec.) 2 (7%)




Detailed overview on age (presented as mean ± SD), sex, pre-
operative motor status, KPS = Karnofsky performance score, tumor
localization, histology (rec. = recurrent) and volume (presented as
median ± IQR) and presence of edema. M1 = tumor inﬁltrates the
motor cortex and approximates≤ 8 mm to the CST, M2 = tumor
seems to “touch” the motor cortex but does not inﬁltrate it nor ap-
proximate to CST≤ 8 mm, subcortical = tumor is subcortically lo-
cated and approximates≤ 8 mm to the CST, other = tumor is not
inﬁltrating or touching the motor cortex nor approximates≤ 8 mm.
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no other signiﬁcant association between presence of edema and neu-
rophysiological parameters could be found (data not shown).
3.3. Comparison of cubic-anatomical vs. speciﬁc-FA-based ROI
Navigated TMS-based FT was successfully performed in all patients
bihemispherically. The estimated FAT did not diﬀer between the two
approaches but between the aﬀected hemisphere (mean FAT for cubic-
anatomical approach 0.24 ± 0.08, mean FAT for speciﬁc-FA-based
approach 0.24 ± 0.08, p = 0.452) and healthy hemisphere (mean
FAT for cubic-anatomical approach 0.30 ± 0.09, mean FAT for spe-
ciﬁc-FA-based approach 0.28 ± 0.09, p = 0.136) (p-value for inter-
hemispheric comparison: p = 0.021 with cubic-anatomical approach,
p = 0.057 with speciﬁc-FA-based approach).
The median number of ﬁbers within the CST could be increased by
180% for the tumorous hemisphere (p < 0.001) and by 160% for the
healthy hemisphere (p = 0.001) by using the speciﬁc-FA-based ROI
instead of the cubic-anatomical ROI (Fig. 3). Although the median
number of tracked ﬁbers is higher on the healthy hemisphere for both
subcortical ROIs (Fig. 3), this did not reach statistical signiﬁcance
(cubic-anatomical ROI p = 0.106, speciﬁc-FA-based ROI p = 0.371).
The presence of edema within the tumorous CST results in a lower FA-
value (see below) and in more producible tracts – independent from the
use of a speciﬁc-FA-based ROI (median 752 ± 645 vs. 147 ± 364,
p = 0.001) or a cubic-anatomical ROI (median 197 ± 588 vs.
90 ± 239, p = 0.057).
Aberrant ﬁbers (=clearly not belonging to the CST) occurred in 24
patients (80%) in the aﬀected hemisphere and in 22 patients (73%) in
the healthy hemisphere when using a cubic-anatomical ROI. In con-
trast, FT with the speciﬁc-FA-based ROI let to appearance of aberrant
ﬁbers in just one patient (3%) for both hemispheres (aﬀected hemi-
sphere and healthy hemisphere respectively p < 0.001). The median
number of aberrant ﬁbers tracked with the cubic-anatomical ROI was
30.5 ± 109 for the tumorous hemisphere and 38 ± 118 for the other
hemisphere.
The comparison of the measured closest distance between tumor
and CST did not show a signiﬁcant diﬀerence depending on the use of a
cubic-anatomical ROI (median 7.0 mm ± 11.25) or speciﬁc-FA-based
ROI (median 6.75 ± 9.13) (p = 0.762).
3.4. Analysis of the FA and ADC value measured within the CST
The measured average FA value within the CST was lower in the
tumorous hemisphere compared to the healthy hemisphere (Table 2,
p = 0.001) – independent from the use of a FA-based or anatomical-
seeded ROI (healthy hemisphere Pearson's r = 0.909 p < 0.001, af-
fected hemisphere Pearson's r = 0.961 p < 0.001). A decreased
average FA value in the tumorous hemisphere was detected when
edema was present within the CST (0.44 ± 0.06 vs. 0.48 ± 0.04,
p = 0.045).
Similarly, a strong accordance in terms of average ADC values
within the CST could be found when comparing both approaches
(healthy hemisphere Pearson's r = 0.890, p < 0.001; aﬀected hemi-
sphere Pearson's r = 0.867, p < 0.001) but the median ADC value was
higher in the tumorous hemisphere compared to the healthy hemi-
sphere (Table 2, p = 0.002). Edema also inﬂuenced the average ADC
value in the aﬀected hemisphere (edema present: 25.3 ± 3.02, edema
not present: 23.7 ± 2.76, p = 0.010).
The spatial changes of the diﬀusion parameters within the CST are
presented in an absolute and relative manner for both hemispheres in
Table 2. Comparison of the FA value at the mesencephal level and the
peritumoral level in the tumorous hemisphere revealed a mean peri-
tumoral decrease of 0.22 for the FA value as could be expected
(p < 0.001). A similar but inverse correlation could be found for the
ADC value in patients with edema within the CST but not reached
statistical signiﬁcance (Table 2). Moreover, signiﬁcant interhemi-
spheric diﬀerences were detected for both, the FA and ADC value, at the
peritumoral level and in average (Table 2). The greater the closest
distance between tumor and CST was the higher was the peritumoral
FA value (Pearson's r = 0.594, p < 0.001, Fig. 4) but no other
Fig. 3. Comparison of the number of ﬁbers produced by
DTI FT of the CST with a cubic anatomical ROI and a spe-
ciﬁc ROI based on the color-coded FA-map for A) the tu-
morous hemisphere and B) for the healthy hemisphere.
Each line represents one patient's number of ﬁbers where
the yellow spotted lines visualize the medians. The use of a
speciﬁc ROI increases the number of CST-ﬁbers by 180%
for the tumorous hemisphere and by 160% for the healthy
hemisphere.
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signiﬁcant relation could be found in terms of tumor-tract-distance and
diﬀusion parameters (data not shown). When analyzing this correlation
without the outlier (#7), there is still a signiﬁcant correlation (Pearson's
r = 0.390, p = 0.036). In terms of presence of edema, equal eﬀects like
described above for the average values could be investigated for the
peritumoral values (Table 2).
Correlation analysis of FA and ADC values shows an inverse corre-
lation in average (Pearson's r =−0.463, p = 0.010), peritumoral
(Pearson's r =−0.496, p = 0.005) and mesencephal (Pearson's
r =−0.748, p < 0.001).
3.5. Analysis of diﬀerent adjusted FA-values
DTI FT was also performed with the same speciﬁc-FA-based ROIs
but diﬀerent adjusted FA-values for all patients. When decreasing the
adjusted FA-value lower than 75% FAT, the incidence of aberrant ﬁbers
increases and consequently the rate of plausible ﬁber tracking results is
lower (Table 3).
3.6. Interrater reliability analysis
The unexperienced as well as the other experienced examiner per-
formed a plausible ﬁber tracking of the CST in all patients. When
analyzing the continuous variables of the examiners' ﬁber tracking, a
signiﬁcant perfect agreement (ICC > 0.8) could be reached for nearly
all parameters – except the average volume of the CST where a mod-
erate agreement (ICC > 0.5) could be veriﬁed (Table 4). No additional
aberrant ﬁbers occurred in the FTs of the other raters which means an
absolute agreement of 97%. The measured closest distance between
tumor and CST – as the clinically most relevant variable of the inter-
rater reliability analysis – is also visualized in Fig. 5.
3.7. Patients outcome
Analysis of the spatial relationship between tumor and eloquent
tissue based on nTMS-mapping and nTMS-based FT revealed a critical
tumor location in 20 patients (67%). Eight patients of them suﬀered
from a paresis that did not recover over time whereas no patient de-
teriorated postoperatively whose tumor location had been determined
as uncritical (outcome day of discharge p = 0.029, outcome after
3 months, p = 0.027). In contrast, 4 patients (13%) could improve their
motor status examined on day of discharge and one more regained
motor function after 3 months. One patient (3%) did not attend to the
follow-up date after 3 months (reason unknown).
Six (55%) out of 11 patients, in which edema was detected within
the CST, got worse in terms of motor function postoperatively versus 2
(11%) out of 19 patients without edema (outcome day of discharge
p = 0.028, outcome after 3 months p = 0.009).
A decreased average FA value is associated with postoperative de-
terioration of motor function at the day of discharge (p = 0.007,
AUC = 0.790 [0.619–0.960] p = 0.017) as well as after 3 months
(p = 0.006, AUC = 0.804 [0.639–0.968] p = 0.013) (Fig. 6). A lower
peritumoral FA value (means 0.37 ± 0.12 vs. 0.45 ± 0.14,
p = 0.110) as such but also its relative decrease in comparison to the
Table 2
Spatial analysis of the diﬀusion parameters (FA and ADC) within the CST.
Parameter/location Aﬀected hemisphere Healthy hemisphere Interhemispheric ratio (aﬀ./heal.) p-Value
Absolute Relative Absolute Relative
FA
Average 0.46 ± 0.05 1 0.51 ± 0.04 1 90% 0.001
“Cortical” 0.26 ± 0.09 57% 0.31 ± 0.09 61% 84% 0.605
Peritumoral 0.40 ± 0.13 87% 0.46 ± 0.11 90% 87% 0.036
/edema 0.34 ± 0.09 74%
\edema 0.44 ± 0.14 96%
Mesencephal 0.62 ± 0.08 135% 0.62 ± 0.11 122% 100% 0.988
Pontine 0.43 ± 0.10 93% 0.47 ± 0.12 92% 91% 0.154
ADC [10−4 mm2/s]
Average 24.47 ± 4.09 1 23.12 ± 2.36 1 106% 0.002
“Cortical” 21.36 ± 4.75 87% 20.52 ± 3.38 89% 104% 0.221
Peritumoral 23.42 ± 5.45 96% 21.80 ± 2.04 94% 107% 0.001
/edema 27.32 ± 8.22 112%
\edema 22.88 ± 4.46 94%
Mesencephal 24.59 ± 6.37 100% 25.55 ± 3.89 111% 96% 0.441
Pontine 20.95 ± 4.39 86% 21.89 ± 3.57 95% 96% 0.339
Detailed overview on FA (presented as mean ± SD) and ADC values (presented as median ± IQR) measured in diﬀerent locations based on speciﬁc-FA-based ROI. “Cortical”=most
cranial part of the CST. /edema = edema was present within the CST. \edema = edema was not present within the CST. The column of relative values allows to identify easily locations
where the corresponding value is higher or lower than in average. An interhemispheric ratio of the absolute values was calculated to analyze diﬀerences between the tumorous and the
healthy hemisphere in detail. Statistic shows that both the FA and ADC value diﬀers signiﬁcantly (p < 0.05) at the peritumoral level (and in average) between the hemispheres.
Fig. 4. Visualization of the relationship between the tumor-
tract-distance and the peritumoral FA-value. Correlation analysis
conﬁrms that there is a signiﬁcant correlation between the dis-
tance and the peritumoral FA-value (Pearson's r = 0.594,
p < 0.001) – even if the outlier is excluded when calculating
Pearson's r (Pearson's r = 0.390, p = 0.036).
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mesencephal level (Fig. 6) showed a relationship with postoperative
impaired motor function (=existence of a postoperative paresis) on day
of discharge, but without statistical signiﬁcance.
Higher ADC values within the CST of the tumorous hemisphere,
measured in average (p = 0.026, Fig. 6) or especially at the peritu-
moral level (median 25.0 ± 8.48 vs. 22.9 ± 3.41, p = 0.038), are
correlated to an aﬀected motor status at day of discharge. When ana-
lyzing the course within the CST, a peritumoral increase of the ADC
value compared to the mesencephal level is also associated with an
aﬀected motor status at day of discharge (p = 0.002, AUC = 0.796
[0.629–0.967] p = 0.007) and after 3 months (p = 0.007,
AUC = 0.719 [0.525–0.913] p = 0.045) (Fig. 6) and is positively cor-
related with postoperative deterioration of motor function (day of
discharge: mean diﬀerence in deteriorated patients = 2.29 ± 6.60 vs.
non-deteriorated patients =−2.13 ± 6.04, p = 0.094; after
3 months: mean diﬀerence in deteriorated patients = 2.29 ± 6.60 vs.
non-deteriorated patients =−2.54 ± 5.87, p = 0.066). The com-
parison of the two hemispheres at the peritumoral level revealed that
higher ADC values on the tumorous hemisphere are related to an af-
fected postoperative motor status (day of discharge: median diﬀerence
in paretic patients = 3.40 ± 6.86 vs. nonparetic patients = 0.97 ±
3.15, p = 0.047; after 3 months: median diﬀerence in paretic pa-
tients = 2.66 ± 7.00 vs. nonparetic patients = 1.49 ± 3.49,
p = 0.150). Moreover, the interhemispheric peritumoral diﬀerence of
the ADC predicted the postoperative motor outcome (day of discharge:
median diﬀerence in deteriorated patients = 4.61 ± 9.91 vs. non-de-
teriorated patients = 1.58 ± 3.86, p = 0.133; after 3 months: median
diﬀerence in deteriorated patients = 4.61 ± 9.91 vs. non-deteriorated
patients = 1.55 ± 3.71, p = 0.088).
4. Discussion
4.1. Background
In patients with aﬀected CST (e.g. by gliomas), utilizing of nTMS
data as seed region for the FT procedure is superior to conventional FT
which only bases on anatomical landmarks. In detail, the insertion of
nTMS data allows to visualize especially perilesional ﬁbers and there-
fore enriches the preoperative planning and intraoperative orientation
(Forster et al., 2015; Frey et al., 2012; Krieg et al., 2012a). Moreover, a
distance between tumor and DTI-derived CST equal or< 8 mm has
been determined as negative predictor in terms of postoperative motor
function which allows to identify high risk cases where intraoperative
neuromonitoring with subcortical stimulation is strongly advised
(Rosenstock et al., 2016). On the other hand, a tumor-tract-dis-
tance< 8 mm not necessarily leads to the occurrence of a new paresis.
Based on our data, the diﬀusion parameters can be used as additional
parameters to estimate more precisely the risk of postoperative func-
tional deterioration.
Since the ﬁrst description of implementing nTMS-data as seed re-
gion into the tracking algorithm by Krieg et al. (2012a), diﬀerent ad-
ditional subcortical ROIs were used where the best available tracking
results for the CST had been reached with an anatomically seeded cubic
ROI in the pons (Weiss et al., 2015). There are some studies suggesting
Table 3
Data from CST-FT depending on diﬀerent adjusted FA-values.
Adjusted
FA-value











tumor and CST [mm]
0.01 22 (73%) 1755 ± 2326 26 (87%) 134 ± 18.50 14.13 ± 9.09 0.41 ± 0.05 27.68 ± 4.95 5.3 ± 8.38
0.05 26 (87%) 1743 ± 2431 22 (73%) 130.5 ± 20.63 12.12 ± 7.55 0.42 ± 0.04 27.72 ± 30.01 5.3 ± 8.38
0.10a 28 (100%) 1135 ± 1884 16 (53%) 126 ± 20.25 8.10 ± 4.63 0.44 ± 0.05 25.71 ± 4.42 6.3 ± 10.88
25% FAT 28 (93%) 1466 ± 2206 21 (70%) 130 ± 21.12 10.98 ± 6.87 0.42 ± 0.05 26.72 ± 5.16 5.65 ± 8.38
50% FAT 30 (100%) 1025 ± 1322 12 (40%) 122 ± 20.80 6.66 ± 4.06 0.44 ± 0.05 25.04 ± 3.99 6.25 ± 10.0
75% FAT 30 (100%) 279 ± 576 1 (3%) 120.5 ± 19.0 3.41 ± 1.89 0.46 ± 0.05 24.47 ± 4.95 6.75 ± 9.13
Detailed overview on the dependency of the adjusted FA-value on the FT parameters. CST = corticospinal tract, FAT = fractional anisotropy threshold, FT = ﬁber tracking. The number
of ﬁbers, the average ﬁber length, the ADC value within the CST and the closest distance between tumor and CST are presented as median ± IQR. The tract volume and the average FA-
value within the CST are presented as mean ± SD.
a In 2 patients, no FT could be performed with an adjusted FA-value of 0.10 because the FAT was lower than 0.10.
Table 4
Interrater reliability results for the FT parameters.
Parameter Mean ± SD or median ± IQR ICC (p value) 95% CI
Rater A Rater B Rater C
Aﬀected hemisphere
Number of ﬁbers 264 ± 615 255 ± 574 141 ± 469 0.868 (< 0.001) 0.76–0.93
FATa 0.24 ± 0.08 0.23 ± 0.08 0.23 ± 0.08 0.982 (< 0.001) 0.97–0.99
Average FAa 0.46 ± 0.05 0.46 ± 0.05 0.47 ± 0.05 0.951 (< 0.001) 0.91–0.98
Average lengthb 120.5 ± 19.0 117 ± 18.25 119 ± 14.75 0.966 (< 0.001) 0.94–0.98
Average volume [cm3]a 3.41 ± 1.89 3.20 ± 1.58 4.75 ± 3.53 0.651 (< 0.001) 0.37–0.82
Average ADC [mm2/s · 10−4]b 24.47 ± 4.09 24.43 ± 3.0 25.20 ± 3.86 0.958 (< 0.001) 0.92–0.98
Distance CST ~ tumor [mm]b 6.75 ± 9.13 7.4 ± 9.50 7.2 ± 8.78 0.993 (< 0.001) 0.99–1.0
Healthy hemisphere
Number of ﬁbersb 369 ± 1232 363 ± 1170 333 ± 1181 0.935 (< 0.001) 0.88–0.97
FATa 0.28 ± 0.09 0.29 ± 0.09 0.29 ± 0.09 0.973 (< 0.001) 0.95–0.99
Average FAa 0.51 ± 0.04 0.51 ± 0.05 0.51 ± 0.05 0.937 (< 0.001) 0.89–0.97
Average lengthb 118 ± 11.75 118.5 ± 12.75 116.5 ± 11.0 0.957 (< 0.001) 0.92–0.98
Average volume [cm3]a 3.12 ± 1.50 2.80 ± 1.36 4.30 ± 3.52 0.586 (0.001) 0.27–0.79
Average ADC [mm2/s · 10−4]b 23.12 ± 1.74 23.20 ± 2.30 23.35 ± 2.92 0.958 (< 0.001) 0.92–0.98
Detailed comparison of the examiners' results where rater A and B are experienced and rater C is unexperienced.
a Data is presented as mean ± SD.
b Data is presented as median ± IQR.
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that nTMS-based DTI FT is less user-dependant than conventional DTI
FT of the CST (Conti et al., 2014; Frey et al., 2012; Krieg et al., 2012a)
but no interrater reliability analysis of the tracking results was per-
formed yet.
Although fMRI-derived ROI seeding for the visualization of the
corticospinal tract has been described (Smits et al., 2007), it has been
criticized – especially in patients suﬀering from a malignant brain
tumor – because of tumor's mass eﬀect and neurovascular decoupling
eﬀects leading to a methodological inaccuracy (Rutten and Ramsey,
2010). A recently published study could show that nTMS-based DTI FT
of the CST is superior in terms of tracking quality and plausibility in
patients with a brain tumor in the vicinity of the primary motor area
compared to fMRI-based approaches (Weiss Lucas et al., 2017). Thus,
the authors recommended the use of the nTMS-technique to identify
seed regions.
4.2. Interrater reliability analysis
This is the ﬁrst study comparing the results of nTMS-based DTI-
derived CST between two experienced and a novice examiner. We want
to highlight that a perfect agreement (ICC > 0.8) could be reached for
all analyzed parameters (except the tract volumes with at least mod-
erate agreement [ICC > 0.5]) with highly statistical signiﬁcance.
Particularly, the very high reliability of the measured tumor-tract-dis-
tance might be the most important result because it is the crucial
parameter for evaluating in how far gross total resection is feasible
without an increased risk for functional deterioration. Thus, nTMS-
based FT can be used to support the surgical strategy planning and
patient counseling in cases with brain tumors in a user-independent and
highly reliable manner without the necessity of an expert user.
4.3. Speciﬁc ROI seeding in the color-coded FA-map
Weiss et al. have been recently shown that an additional anato-
mical-seeded cubic ROI beside the nTMS-based ROI can increase the
feasibility rates of DTI FT of the ipsilesional CST up to 94% for the
upper and in 81% for the lower extremity (Weiss et al., 2015).
The speciﬁc ROI seeding for DTI FT of the CST based on color-coded
FA maps in the caudal pons in patients with glioma aﬀecting the motor
system has been described for the ﬁrst time in the present study (Fig. 1).
A plausible FT of the CST could be performed in each patient for both
the upper and lower extremity with the speciﬁc ROI. Moreover, the FT
with the speciﬁc ROI reveals more CST ﬁber bundles which had been
judged as plausible by our interdisciplinary board of neurosurgeons and
neuroradiologists. On the other hand, the speciﬁc ROI reduces the
prevalence of aberrant ﬁbers (rater A: 3%, rater B and C: 0%) and al-
lows an improved analysis of the spatial relationship between func-
tional tissue and tumor.
In this study, we used the FA thresholding algorithm of Frey et al.
(2012), but we also performed FT with diﬀerent adjusted FA values in a
dense raster. When decreasing the adjusted FA value under 75% FAT,
the plausibility rate is not longer 100% where aberrant ﬁbers appeared
Fig. 5. Visualization of the closest distance between tumor and
CST measured by two experienced (rater A and B) and one un-
experienced examiner (rater C). Interrater reliability analysis
conﬁrms a perfect agreement (ICC = 0.993, p < 0.001).
Fig. 6. Box plots illustrating the distribution of the diﬀu-
sion parameters and their intrahemispheric diﬀerence be-
tween the mesencephal and the peritumoral level, ac-
cording to the postoperative motor outcome or status,
respectively. Lower average FA-values within the tumorous
CST (A) are signiﬁcantly associated with postoperative
deterioration of the motor system after 3 months. An ex-
isting motor deﬁcit on day of discharge is in relation to
higher average ADC-values within the tumorous CST (B).
Comparison of the diﬀusion parameters in diﬀerent loca-
tions (mesencephal vs. peritumoral) revealed that high
diﬀerences could be especially found in patients with an
impaired motor status on day of discharge (C) or after
3 months (D), respectively.
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more often. In Addition, the tumor-tract-distance decreases and might
lead to inadequate interpretation of tracking results. Therefore we ad-
vise to follow the established thresholding and to not lower the adjusted
FA value under 75% FAT when performing DTI FT of the CST.
The results of the interrater reliability analysis and the comparison
of anatomical vs. color-coded FA-map ROI seeding suggest that our
standardized procedure increases the tracking quality and seems to be
superior towards tracking algorithms published so far.
4.4. Diﬀusivity parameters and edema
This is the ﬁrst study analyzing the FA and ADC value within the
nTMS-based DTI-derived CST in diﬀerent locations in patients with
glioma approximating the CST.
We could show that the FA value is lower and the ADC value is
higher in the aﬀected hemisphere – especially at the peritumoral level.
This ﬁnding goes in line with two other studies presenting a similar
interhemispheric diﬀerence for the FA value within a non-functional
DTI-derived CST in patients with subcortical glioma (Giordano et al.,
2015; Stadlbauer et al., 2007). Moreover, there are current meta-ana-
lyses of DTI studies suggesting that decreased FA values caused by
diﬀerent neurological diseases (e.g. ischemic stroke, intracerebral he-
morrhage, Huntington's disease) are associated with an aﬀected motor
status (Chen et al., 2016; Kumar et al., 2016a; Kumar et al., 2016b; Liu
et al., 2016). Just one study previously showed in patients with various
brain tumor entities, that an aﬀected preoperative motor status seems
to be in relationship with interhemispheric diﬀerences of the FA and
ADC value based on non-functional DTI-derived CSTs (Bobek-Billewicz
et al., 2011). This ﬁts well with our ﬁndings that interhemispheric
diﬀerences of the diﬀusivity parameters can be used preoperatively to
predict the postoperative motor outcome. In addition, the comparison
of the diﬀusivity parameters at diﬀerent locations revealed that the FA
and ADC value are especially aﬀected at the peritumoral level of the
tumorous hemisphere only. Consequently, no signiﬁcant interhemi-
spheric diﬀerence in terms of diﬀusivity could be found elsewhere.
It is widely known that tracking results are often impaired in pa-
tients with brain tumors by tumor mass eﬀects and perilesional edema
because anisotropic diﬀusivity is disturbed (Mandelli et al., 2014;
Schonberg et al., 2006; Zolal et al., 2013). The peritumoral decrease of
the FA value and increase of the ADC value found in our patients –
especially when edema was present – go in line with the current state of
research (Lu et al., 2003), however the spatial speciﬁc impairment of
the diﬀusivity parameters at the peritumoral level has been examined
for the ﬁrst time.
One study showed that nTMS is sometimes not feasible when (ex-
cessive) edema is present (Conti et al., 2014). In contrast, we could
elicit MEPs in all our patients with RMT values of the tumorous
hemisphere being signiﬁcant lower in patients with edema within the
CST. Sollmann et al. could show an equal decrease of the RMT for tu-
morous edematous hemispheres in patients with various tumor entities
and described this phenomenon as increased excitability caused by
decreased plasma osmolality (Sollmann et al., 2017). Following this
hypothesis, an increased excitability of the tumorous hemisphere could
explain lower healthy hemisphere MEP amplitudes caused by inter-
hemispheric inhibition (Davidson and Tremblay, 2013; Perez and
Cohen, 2009). A better permeability of the induced e-ﬁeld due to the
edema may also explain the decreased RMT of the tumorous hemi-
sphere.
Another study reported that presence of edema lead to implausible
FT results (Weiss et al., 2015). In our patients, a plausible FT could be
performed in each case where aberrant ﬁbers just occurred in one case.
In the present study, the presence of edema rather resulted in a higher
number of ﬁbers belonging to the CST and might conﬁrm our opinion
that the presented nTMS-based FT procedure is a robust method for
evaluating in how far the tumor location is risky in terms of post-
operative motor deterioration – even if peritumoral edema is present
within the course of the CST. It needs to be stressed that a strong cor-
relation between the presence of edema within the CST and an impaired
postoperative motor status was observed in our study.
Further research is needed to better understand in how far edema
and intracortical/interhemispheric excitation-inhibition-balancing in-
ﬂuence the motor system's functionality in patients with brain lesions.
Moreover, prospective study's attention should be payed especially to
the peritumoral level when analyzing the DTI-derived CST in brain
tumor patients. It is remarkable that an impaired postoperative motor
status correlates with the extent of diﬀusivity-disturbance within the
tumorous CST (peritumoral vs. mesencephal level).
4.5. Limitations
All presented results of this study are based on a consecutive cohort
of 30 patients treated in our department. Thus, we cannot exclude that
our results were inﬂuenced by the speciﬁc decision-making processes
and treatment algorithms of our department.
Although there are some studies suggesting that better tracking
results of the CST can be reached with probabilistic FT (Bucci et al.,
2013; Mandelli et al., 2014) instead of deterministic approaches, no
comparison between nTMS-based FT results have been published in this
respect yet. Also, the main advantage of probabilistic FT with voxel
deconvolution is claimed for its robustness against edema – in our study
deterministic DTI FT was successful despite the presence of edema in all
cases. Seeding of speciﬁc functional ROIs in motor-associated tumor
locations is essential for evaluating the spatial relationship between
eloquent area and tumorous tissue because this is the only method to
reliably account for tumor-induced neuronal plasticity and rearrange-
ment of the motor pathway (Duﬀau, 2007; Krieg et al., 2012a; Lehericy
et al., 2000) which cannot be considered when just using anatomical
landmarks. Furthermore, deterministic FT is more time-eﬃcient and
more useful in clinical context when treating and counseling patients
where standardized procedures are required.
The accuracy of the nTMS-based FT has been recently shown
(Forster et al., 2015) and all tracking results were critically analyzed by
our interdisciplinary board including neurosurgeons and neuroradiol-
ogists. Nevertheless, the number of ﬁbers as a parameter to assess the
quality of tractography is a weak and controversial measure. Moreover,
a validation of the ﬁbers in brain tumor patients by subcortical stimu-
lation is challenging due to brain shift and electrical current spread.
5. Conclusions
Navigated TMS-based motor DTI not only oﬀers data for analyzing
the spatial relationship between tumor and functionally essential tissue
but also provides information on the structural integrity of the tracts,
which improves the patient counseling and the prediction of post-
operative motor outcome. A second subcortical ROI, speciﬁcally seeded
based on the color-coded FA map, increases the tracking quality of the
CST and is highly reliable – independently of the examiner's experience.
Further prospective studies are needed to validate the nTMS-based
prediction of the patient's outcome.
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